A first insight into the genotypic diversity of Mycobacterium tuberculosis from Rwanda

BMC Clinical Pathology

Volumn 12, Issue , 2012, Pages

  Gafirita, James ^a,b   Umubyeyi, Alaine N ^a   Asiimwe, Benon B ^b  

^a UNIVERSITY OF RWANDA   (Rwanda)

^b MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DRUG SENSITIVITY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RWANDA; SERODIAGNOSIS; SPUTUM ANALYSIS;

EID: 84868293010     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-12-20     Document Type: Article

References (36)

1. Deoxyribonucleic acid relatedness among selected strains of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium bovis BCG, Mycobacterium microti and Mycobacterium africanum. Imaeda T, Int J Syst Bacteriol 1985 35 147 150 10.1099/00207713-35-2-147
2. Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. Kallenius G, et al. J Clin Microbiol 1999 37 12 3872 3878 10565899
3. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Gagneux S, et al. Proc Natl Acad Sci U S A 2006 103 8 2869 2873 10.1073/pnas.0511240103 16477032
4. Mycobacterium tuberculosis Uganda genotype is the predominant cause of TB in Kampala, Uganda. Asiimwe BB, et al. Int J Tuberc Lung Dis 2008 12 4 386 391 18371263
5. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. van Soolingen D, et al. J Clin Microbiol 1995 33 12 3234 3238 8586708
6. Predominance of a single genotype of Mycobacterium tuberculosis in regions of Southern Africa. Chihota V, et al. Int J Tuberc Lung Dis 2007 11 3 311 318 17352098
7. Molecular characteristics of strains of the cameroon family, the major group of Mycobacterium tuberculosis in a country with a high prevalence of tuberculosis. Niobe-Eyangoh SN, et al. J Clin Microbiol 2004 42 11 5029 5035 10.1128/JCM.42.11.5029-5035.2004 15528691
8. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Hirsh AE, et al. Proc Natl Acad Sci U S A 2004 101 14 4871 4876 10.1073/pnas.0305627101 15041743
9. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. Caws M, et al. PLoS Pathog 2008 4 3 1000034 10.1371/journal.ppat.1000034 18369480
10. Discovery of a novel Mycobacterium tuberculosis lineage that is a major cause of tuberculosis in Rio de Janeiro, Brazil. Lazzarini LC, et al. J Clin Microbiol 2007 45 12 3891 3902 10.1128/JCM.01394-07 17898156
11. RDRio Mycobacterium tuberculosis infection is associated with a higher frequency of cavitary pulmonary disease. Lazzarini LC, et al. J Clin Microbiol 2008 46 7 2175 2183 10.1128/JCM.00065-08 18463217
12. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Victor TC, et al. Int J Tuberc Lung Dis 2007 11 2 195 201 17263291
13. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. Umubyeyi AN, et al. Int J Infect Dis 2008 12 2 152 156 10.1016/j.ijid.2007.05.003 17950021
14. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Umubyeyi AN, et al. Int J Tuberc Lung Dis 2007 11 2 189 194 17263290
15. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. Umubyeyi A, et al. Int J Infect Dis 2008 12 2 152 156 10.1016/j.ijid.2007.05.003 17950021
16. Molecular investigation of recurrent tuberculosis in patients from Rwanda. Umubyeyi AN, et al. Int J Tuberc Lung Dis 2007 11 8 860 867 17705951
17. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. Brudey K, et al. BMC Microbiol 2006 6 23 10.1186/1471-2180-6-23 16519816
18. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala. Asiimwe BB, et al. Uganda. BMC Infect Dis 2008 8 101
19. Kent PT, Kubica GP, Public health mycobacteriology: a guide for the level III laboratory Department of Public Health and Human Services, Public Health Service, Centres for Disease Control, Atlanta, US 1985
20. Aziz MA, Laszlo A, Raviglione M, Rieder H, Espinal M, Wright A, Guidelines for surveillance of drug resistance in tuberculosis World Health Organization 2 2003 Document WHO/CDS/CSR/RMD/2003.3. http://whqlibdoc.who.int/ publications/2003/9241546336.pdf. Accessed November 5, 2012
21. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. van Embden JD, et al. J Clin Microbiol 1993 31 2 406 409 8381814
22. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Brosch R, et al. Proc Natl Acad Sci U S A 2002 99 6 3684 3689 10.1073/pnas.052548299 11891304
23. PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. Huard RC, et al. J Clin Microbiol 2003 41 4 1637 1650 10.1128/JCM.41.4.1637-1650.2003 12682155
24. Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex. Huard RC, et al. J Bacteriol 2006 188 12 4271 4287 10.1128/JB.01783-05 16740934
25. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. Kamerbeek J, et al. J Clin Microbiol 1997 35 4 907 914 9157152
26. The species Mycobacterium africanum in the light of new molecular markers. Niemann S, et al. J Clin Microbiol 2004 42 9 3958 3962 10.1128/JCM.42.9.3958-3962.2004 15364975
27. A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping. Eldholm V, et al. BMC Microbiol 2006 6 76 10.1186/1471-2180-6-76 16970826
28. Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. Niobe-Eyangoh SN, et al. J Clin Microbiol 2003 41 6 2547 2553 10.1128/JCM.41.6.2547-2553.2003 12791879
29. Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia. de Jong BC, et al. J Clin Microbiol 2009 47 4 994 1001 10.1128/JCM.01216-08 19193842
30. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda. Bazira J, et al. BMC Infect Dis 2011 11 81 10.1186/1471-2334-11-81 21453482
31. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. Kibiki GS, et al. BMC Microbiol 2007 7 51 10.1186/1471-2180-7-51 17540031
32. Characterization of Finnish Mycobacterium tuberculosis isolates by spoligotyping. Puustinen K, et al. J Clin Microbiol 2003 41 4 1525 1528 10.1128/JCM.41.4.1525-1528.2003 12682140
33. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. Niemann S, et al. J Clin Microbiol 2002 40 9 3398 3405 10.1128/JCM.40.9.3398-3405.2002 12202584
34. High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological study. Easterbrook PJ, et al. J Clin Microbiol 2004 42 10 4536 4544 10.1128/JCM.42.10.4536-4544.2004 15472306
35. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Gagneux S, Small PM, Lancet Infect Dis 2007 7 5 328 337 10.1016/S1473-3099(07)70108-1 17448936
36. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. Bretzel G, et al. Int J Tuberc Lung Dis 1999 3 9 810 815 10488890